Drug Patents owned by Pragma

1. Drug name - DESYREL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8133893 PRAGMA Trazodone and trazodone hydrochloride in purified form
Mar, 2029

(6 years from now)

CN101772490A PRAGMA Trazodone And Trazodone Hydrochloride In Purified Form
Jul, 2028

(5 years from now)

CN101772490B PRAGMA Purification Trazodone And Trazodone Hydrochloride Form
Jul, 2028

(5 years from now)

IN201001179P4 PRAGMA Trazodone And Trazodone Hydrochloride In Purified Form
Jul, 2028

(5 years from now)

IN285451B PRAGMA A Process Of Production Of Purified Form Of Trazodone And Trazodone Hydrochloride
Jul, 2028

(5 years from now)

EP2178850A1 PRAGMA Trazodone And Trazodone Hydrochloride In Purified Form
Jul, 2028

(5 years from now)

EP2178850B1 PRAGMA Trazodone And Trazodone Hydrochloride In Purified Form
Jul, 2028

(5 years from now)

More Information on Dosage
Strength Dosage Availability
50MG TABLET;ORAL Discontinued
100MG TABLET;ORAL Discontinued
150MG TABLET;ORAL Discontinued
300MG TABLET;ORAL Discontinued

2. Drug name - MOXATAG

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8778924 PRAGMA Modified release amoxicillin products
Dec, 2026

(4 years from now)

CN101563466A PRAGMA Modified Release Amoxicillin Products
Aug, 2016

(6 years ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8357394 PRAGMA Compositions and methods for improved efficacy of penicillin-type antibiotics Dec, 2026

(4 years from now)

US8299052 PRAGMA Pharmaceutical compositions and methods for improved bacterial eradication May, 2027

(4 years from now)

Drugs and Companies using AMOXICILLIN ingredient

Treatment: Use of once-a-day amoxicillin product to treat tonsillitis and/or pharyngitis secondary to streptococcus pyogenes

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
775MG TABLET, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.